UCL logo

UCL Discovery

UCL home » Library Services » Electronic resources » UCL Discovery

Browse by UCL Departments and Centres

Up a level
Export as [feed] RSS 2.0 [feed] RSS 1.0 [feed] Atom
Group by: Author | Type
Jump to: A | B | C | D | E | G | H | J | K | L | M | N | O | P | R | S | T | V | W
Number of items: 145.

A

Ah- See, ML and Burcombe, RJ and Daley, FM and Richman, P and Padhani, AR and Bentzen, SM and Fox, SB and Harris, AL and Makris, A (2005) Evaluation of tunour microvessel density and pericyte coverge index following neoadjuvant chemotherapy in primary breast cancer. In: Proceedings of of ASCO. (pp. 42s - 42s).

Ah-See, M and Makris, A and Taylor, NJ and Stirling, JJ and Daley, FM and Richman, P and Harris, A and d'Arcy, J and Collins, D and Padhani, AR (2005) Correlating breast cancer and hypoxia status with MRI features. In: Breast Cancer Research and Treatment. (pp. S205 - ?).

Ah-See, M and Padhani, AR and Taylor, NJ and Harris, AL and Burcombe, RJ and Fox, SB and Richman, PI and Daley, FM and Stirling, JJ and Leach, MO and Bentzen, SM and Makris, M (2005) Lack of correlation between microvessel density & pericyte coverage index with breast cancer biposies & functional dynamic contrast-enhanced MRI-derived vascular parameters. In: Breast Cancer Research and Treatment. (pp. S74 - S75).

Ah-See, MW and Harris, AL and Burcombe, RJ and Fox, SB and Richman, PI and Daley, FM and Padhani, AR and Bentzen, SM and Makris, A (2005) Evaluation of the effects of neoadjuvant chemotherapy on tumour microvessel density(MVD), pericyte coverage index(PCI), & vascular enodthelial growth factor(VEGF)in primary breast cancer. In: Breast Cancer Research and Treatment. (pp. S224 - ?).

Alonzi, R and Hoskin, P (2005) Novel therapies in bladder cancer. CLINICAL ONCOLOGY , 17 (7) 524 - 538.

Andy, S (2005) My dad’s fight with lung cancer. Daily Express 30 - 31.

Ardeshna, KM and Kakouros, N and Qian, W and Powell, MG and Saini, N and D'Sa, S and Mackinnon, S and Hoskin, PJ and Goldstone, AH and Linch, DC (2005) Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens. BRITISH JOURNAL OF HAEMATOLOGY , 130 (3) 363 - 372.

Arkenau, H and Kubicka, S and Greil, R and Schmoll, H and Seufferlein, T and Greaven, U and Grothey, A and Kretschmar, A and Hinke, A and Porschen, R (2005) Infusional 5-fluorouracil/folinic acid plus oxaliplatin (FUFOX) versus Capecitabine plus oxaliplatin (CAPOX) as first line treatment of metastatic colorectal carcinoma (MCRC): results of the safety and efficacy analysis. EJC SUPPL , 3 (2) 168 - 168.

Arkenau, H and Porschen, R (2005) Adjuvante Therapie des Kolonkarzinoms. In: Schoelmerich, J and Schmiegel, W, (eds.) Leitfaden Kolorektales Karzinom. (175 - 183). Uni-Med.-Verlag: Bremen, Germany.

Arkenau, HT and Müssig, O and Buhr, T and Jend, HH and Porschen, R (2005) Microangiopathic hemolytic anemia (MAHA) as paraneoplastic syndrome in metastasized signet ring cell carcinomas: case reports and review of the literature. Z Gastroenterol , 43 (8) 719 - 722. 10.1055/s-2005-858259.

Arkenau, HT and Rettig, K and Porschen, R (2005) Adjuvant chemotherapy in curative resected colon carcinoma: 5-fluorouracil/leucovorin versus high-dose 5-fluorouracil 24-h infusion/leucovorin versus high-dose 5-fluorouracil 24-h infusion. Int J Colorectal Dis , 20 (3) 258 - 261. 10.1007/s00384-004-0657-6.

Attard, G and Plummer, RE and De Bono, JS and Bale, C and Fong, P and Barrett, M and Fox, NL and Howard, T and Ullrich, S and Calvert, H (2005) Phase I and pharmacokinetic study of HGS-ETR2, a fully human agonistic monoclonal antibody to TRAIL-R2, in patients with advanced solid malignancies. In: CLINICAL CANCER RESEARCH. (pp. 9060S - 9060S). AMER ASSOC CANCER RESEARCH

Azzabi, A and Hughes, AN and Calvert, PM and Plummer, ER and Todd, R and Griffin, MJ and Lind, MJ and Maraveyas, A and Kelly, C and Fishwick, K and Calvert, AH and Boddy, AV (2005) Phase I study of temozolomide plus paclitaxel in patients with advanced malignant melanoma and associated in vitro investigations. BRIT J CANCER , 92 (6) 1006 - 1012. 10.1038/sj.bjc.6602438.

B

Barber, LJ and Ward, TA and Hartley, JA and McHugh, PJ (2005) DNA interstrand cross-link repair in the Saccharomyces cerevisiae cell cycle: Overlapping roles for PSO2 (SNM1) with MutS factors and EXO1 during S phase. MOL CELL BIOL , 25 (6) 2297 - 2309. 10.1128/MCB.25.6.2297-2309.2005.
An open access publication

BBC, NB (2005) Lung cancer scientist dies at 92. UNSPECIFIED

BBC, NO (2005) 'Freeze therapy' for lung cancers. UNSPECIFIED

BBC, NO (2005) Thalidomide slows cancer disease. UNSPECIFIED

BBC, NO (2005) Warning to heed lung cancer signs. UNSPECIFIED

Begent, RHJ and Kerr, P and Parkinson, H and Reddington, F and Wilkinson, JM (2005) NCRI Informatics initiative. UNSPECIFIED

Bentzen, SM and Atasoy, BM and Daley, FM and Dische, S and Richman, PI and Saunders, MI and Trott, KR and Wilson, GD (2005) Epidermal growth factor receptor expression in pre-treatment biopsies from head and neck squamous cell carcinoma as a predictive factor for a benefit from accelerated radiation therapy in a randomised controlled trial. Journal of Clinical Oncology , 23 (24) 5560 - 5567. 10.1200/jco.2005.06.411.

Beresford, M and Ah-See M L, T and N J, S and J J, M and A, DJA and Leach, MO and Padhani, AR (2005) Inter-and intra-observer variability of DCE-MRI in breast cancer. In: Proceedings of the International Society of Magnetic Resonance Medicine.

Beresford, M and Glynne-Jones, R and Richman, P and Makris, A and Mawdsley, S and Stott, D and Harrison, M and Osborne, M and Ashford, R and Grainger, J and Al-Jabbour, J and Talbot, I and Mitchell, IC and Thomas, JM and Livingstone, JI and McCue, J and MacDonald, P and Northover, JAM and Windsor, A and Novell, R and Wallace, M and Harrison, RA (2005) The reliability of lymph-node staging in rectal cancer after preoperative chemoradiotherapy. CLINICAL ONCOLOGY , 17 (6) 448 - 455.

Beresford, M and Padhani, AR and Goh, V and Makris, A (2005) Imaging breast cancer response during neoadjuvant systemic therapy. Expert Review of Anticancer Therapy , 5 (5) 893 - 905.

Beresford, MJ and Ah-See, M and Daley, F and Richman, P and Harris, A and Makris, A (2005) The role of the angiogenic marker, endoglin, as a predictor of response to neoadjuvant chemotherapy in primary bresat cancer. In: Breast Cancer Research and Treatment. (pp. S59 - S59).

Beresford, MJ and Ah-See, ML and Burcombe, R and Dixon, J and Ostler, P and Harrsion, M and Pittam, R and R, M and A, (2005) Do pre-treatment haemaglobin levels predicct for response to neoadjuvant chemotherapy in breast cancer? In: Proc of ASCO. (pp. 80s - 80).

Beresford, MJ and Makris, A and Taylor, NJ and Stirling, JJ and Ah-See, M and d'Arcy, JA and Collins, D and Padhani, AR (2005) Observer variability in dynamic contrast-enhanced MRI when used for prediction of response to neoadjuvant chemotherapy in primary breast cancer. In: Breast Cancer Research and Treatment. (pp. S206 - ?).

Birtle, AJ and Freeman, A and Masters, JRW and Payne, HA and Harland, SJ and Baus Section Oncology Canc Registr, (2005) Tumour markers for managing men who present with metastatic prostate cancer and serum prostate-specific antigen levels of < 10 ng/mL. BJU INT , 96 (3) 303 - 307. 10.1111/j.1464-410X.2005.05619.x.

Boddy, AV and Plummer, ER and Todd, R and Sludden, J and Griffin, M and Robson, L and Cassidy, J and Bissett, D and Bernareggi, A and Verrill, MW and Calvert, AH (2005) A phase I and pharmacokinetic study of paclitaxel poliglumex (XYOTAX), investigating both 3-weekly and 2-weekly schedules. CLIN CANCER RES , 11 (21) 7834 - 7840. 10.1158/1078-0432.CCR-05-0803.

Boxer, GM and Tsiompanou, E and Levine, T and Watson, R and Begent, RHJ (2005) Immunohistochemical expression of vascular endothelial growth factor and microvessel counting as prognostic indicators in node-negative colorectal cancer. TUMOR BIOL , 26 (1) 1 - 8. 10.1159/000084180.

Braybrooke, JP and Slade, A and Deplanque, G and Harrop, R and Madhusudan, S and Forster, MD and Gibson, R and Makris, A and Talbot, DC and Steiner, J and White, L and Kan, O and Naylor, S and Carroll, MW and Kingsman, SM and Harris, AL (2005) Phase I study of MetXia-P450 gene therapy and oral cyclophosphamide for patients with advanced breast cancer or melanoma. Clin Cancer Res , 11 (4) 1512 - 1520. 10.1158/1078-0432.CCR-04-0155.

Brooks, S and Bownes, P and Lowe, G and Bryant, L and Hoskin, PJ (2005) Cervical brachytherapy utilizing ring applicator: comparison of standard and conformal loading. International Journal of Radiation Oncology Biology Physics , 63 (3) 934 - 939.

Buchmueller, KL and Taherbhai, Z and Howard, CM and Bailey, SL and Nguyen, B and O'Hare, C and Hochhauser, D and Hartley, JA and Wilson, WD and Lee, M (2005) Design of a hairpin polyamide, ZT65B, for targeting the inverted CCAAT box (ICB) site in the multildrug resistant (MDR1) gene. CHEMBIOCHEM , 6 (12) 2305 - 2311. 10.1002/cbic.200500179.

Burcombe, RJ and Makris, A and Richman, PI and Daley, FM and Noble, S and Pittam, M and Wright, D and Allen, SA and Dove, J and Wilson, GD (2005) Evaluation of ER, PgR, HER-2 and Ki-67 as predictors of response to neoadjuvant anthracycline chemotherapy for operable breast cancer. British Journal of Cancer , 92 (1) 147 - 155.

Burton, C and Smith, P and Vaughan-Hudson, G and Qian, W and Hoskin, P and Cunningham, D and Hancock, B and Linch, D (2005) Comparison of CHOP versus CIOP in good prognosis younger patients with histologically aggressive non-Hodgkin lymphoma. BRITISH JOURNAL OF HAEMATOLOGY , 130 (4) 536 - 541.

C

Calvert, AH (2005) Fishing for new drugs. J CLIN ONCOL , 23 (31) 7780 - 7782. 10.1200/JCO.2005.08.004.

Calvert, H and Twelves, C and Ranson, M and Anthoney, A and Plummer, R and Fettner, S and Dayaram, B and Lum, B and Hamilton, M and Rakhit, A (2005) The effect of erlotinib on CYP3A4 activity, as quantified by the erythromycin breath test and oral midazolam kinetics in cancer patients: Preliminary results. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 210S - 210S). AMER SOC CLINICAL ONCOLOGY

Capponcelli, S and Pedrini, E and Cerone, MA and Corti, V and Fontanesi, S and Alessio, M and Bachi, A and Soddu, S and Ribatti, D and Picci, P and Helman, LJ and Cantelli-Forti, G and Sangiorgi, L (2005) Evaluation of the molecular mechanisms involved in the gain of function of a Li-Fraumeni TP53 mutation. Hum Mutat , 26 (2) 94 - 103. 10.1002/humu.20192.

Casely-Hayford, MA and Pors, K and James, CH and Patterson, LH and Hartley, JA and Searcey, M (2005) Design and synthesis of a DNA-crosslinking azinomycin analogue. ORG BIOMOL CHEM , 3 (19) 3585 - 3589. 10.1039/b508908e.

Cerone, MA and Autexier, C and Londoño-Vallejo, JA and Bacchetti, S (2005) A human cell line that maintains telomeres in the absence of telomerase and of key markers of ALT. Oncogene , 24 (53) 7893 - 7901. 10.1038/sj.onc.1208934.

Cerone, MA and Ward, RJ and Londoño-Vallejo, JA and Autexier, C (2005) Telomerase RNA mutated in autosomal dyskeratosis congenita reconstitutes a weakly active telomerase enzyme defective in telomere elongation. Cell Cycle , 4 (4) 585 - 589.

Chang, JC and Hisenback, SG and Yee, D and Tsimelzon, A and Harrison, M and Gutierrez, CM and Elledge, RM and O'Connell, PO and P J, O and K C, M and S, M and A, (2005) Gene expression profiles as predictors of response to neoadjuvant taxotere and adriamycin/cyroxan:a propsective randomized trial in breast cancers. In: Breast Cancer Research Treatment. (pp. S31 - S31).

Chester, KA and Baker, M and Mayer, A (2005) Overcoming the immunologic response to foreign enzymes in cancer therapy. Expert Rev Clin Immunol , 1 (4) 549 - 559. 10.1586/1744666X.1.4.549.

Cheung, CW and Burton, C and Smith, P and Linch, DC and Hoskin, PJ and Ardeshna, KM (2005) Central nervous system chemoprophylaxis in non-Hodgkin lymphoma: current practice in the UK. BRIT J HAEMATOL , 131 (2) 193 - 200. 10.1111/j.1365-2141.2005.05756.x.

Cleator, SJ and Makris, A and Ashley, SE and Lal, R and Powles, TJ (2005) Good clinical response of breast cancers to neoadjuvant chemoendocrine therapy is associated with improved overall survival. Annals of Oncology , 16 (2) 267 - 272.

Clingen, PH and De Silva, IU and McHugh, PJ and Ghadessy, FJ and Tilby, MJ and Thurston, DE and Hartley, JA (2005) The XPF-ERCC1 endonuclease and homologous recon bination contribute to the repair of minor groove DNA interstrand crosslinks in mammalian cells produced by the pyrrolo[2,1-c][1,4]benzodiazepine dimer SJG-136. NUCLEIC ACIDS RES , 33 (10) 3283 - 3291. 10.1093/nar/gki639.
An open access publication

Corrie, PG and Shaw, J and Spanswick, VJ and Sehmbi, R and Jonson, A and Mayer, A and Bulusu, R and Hartley, JA and Cree, IA (2005) Phase I trial combining gemcitabine and treosulfan in advanced cutaneous and uveal melanoma patients. BRIT J CANCER , 92 (11) 1997 - 2003. 10.1038/sj.bjc.6602586.

D

Daniell, K and Stewart, M and Madsen, E and Le, M and Handl, H and Brooks, N and Kiakos, K and Hartley, JA and Lee, M (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. BIOORG MED CHEM LETT , 15 (1) 177 - 180. 10.1016/j.bmcl.2004.10.021.

Daniell, K and Stewart, M and Madsen, E and Le, M and Handl, H and Brooks, N and Kiakos, K and Hartley, JA and Lee, M (2005) Design, synthesis, and biological evaluation of achiral analogs of duocarmycin SA. Bioorg Med Chem Lett , 15 (1) 177 - 180. 10.1016/j.bmcl.2004.10.021.

Dark, GG and Calvert, AH and Grimshaw, R and Poole, C and Swenerton, K and Kaye, S and Coleman, R and Jayson, G and Le, T and Ellard, S and Trudeau, M and Vasey, P and Hamilton, M and Cameron, T and Barrett, E and Walsh, W and McIntosh, L and Eisenhauer, EA (2005) Randomized trial of two intravenous schedules of the topoisomerase I inhibitor liposomal lurtotecan in women with relapsed epithelial ovarian cancer: A trial of the National Cancer Institute of Canada Clinical Trials Group. JOURNAL OF CLINICAL ONCOLOGY , 23 (9) 1859 - 1866. 10.1200/JCO.2005.02.028.

Dearling, JLJ and Flynn, and AA, and Beken, L and Petrie, and IA, and El-Emir, and E, and Boxer, and GM, and Green, AJ and Begent, and RHJ, AP and RB, (2005) Dose estimation in a 3D tumour reconstruction – Impact of the heterogeneity of tumour pathophysiology on RIT and EBRT. In: European Journal of Nuclear Medicine and Molecular Imaging. (pp. 83 - ?).

Dearling, JLJ and Qureshi, U and Begent, and RHJ, and Pedley, RB (2005) Radioimmunotherapy combined with anti-hypoxia therapy 2DG results in reduction of therapeutic efficacy. In: European Journal of Nuclear Medicine and Molecular Imaging. (pp. 48 - ?).

Dearling, JLJ and Qureshi, U and Begent, RHJAPRB (2005) RIT given in combination with anti-hypoxia therapy 2DG leads to loss of therapeutic efficacy. In: (Proceedings) NCRI cancer Conference Proceedings. (pp. 66 - ?).

Dearling, JLJ and Qureshi, U and Whiting, S and Boxer, and GM, and Begent, and RHJ, APR (2005) Analysis of antibody distribution reveals higher uptake in peripheral intrahepatic deposits than central deposits. In: European Journal of Nuclear Medicine and Molecular Imaging. (pp. 83 - ?).

Dearling, JLJ and Qureshi, U and Whiting, S and Boxer, G and Begent, RHJAPRB (2005) Quantitative autoradiography revelas higher antibody uptake in peripheral intrahepatic deposits than in central deposits. In: (Proceedings) NCRI Cancer Conference Proceedings. (pp. 56 - ?).

Deborah, H (2005) I haven’t smoked for 23 years yet now I face the serves-you-right stigma of this forgotten disease. Evening Standard 27 - 28.

E

El, EE and Dearling, J and Huhalov, A and Neri, D and Begent, RHJ and Pedley, RB (2005) Targeting tumour vasculature in human colorectal xenografts using against the extra-domain B of fibronectin. In: (Proceedings) NCRI Cancer Conference proceedings.

El-Emir, E and Boxer, GM and Petrie, IA and Boden, RW and Dearling, JLJ and Begent, RHJ and Pedley, RB (2005) Tumour parameters affected by combretastatin A-4 phosphate therapy in a human colorectal xenograft model in nude mice. EUR J CANCER , 41 (5) 799 - 806. 10.1016/j.ejca.2005.01.001.

G

Gibbs, DD and Theti, DS and Wood, N and Green, M and Raynaud, F and Valenti, M and Forster, MD and Mitchell, F and Bavetsias, V and Henderson, E and Jackman, AL (2005) BGC 945, a novel tumor-selective thymidylate synthase inhibitor targeted to alpha-folate receptor-overexpressing tumors. Cancer Res , 65 (24) 11721 - 11728. 10.1158/0008-5472.CAN-05-2034.

Guest, RD and Hawkins, RE and Kirillova, N and Cheadle, EJ and Arnold, J and O'Neill, A and Irlam, J and Chester, KA and Kemshead, JT and Shaw, DM and Embleton, MJ and Stern, PL and Gilham, DE (2005) The role of extracellular spacer regions in the optimal design of chimeric immune receptors - Evaluation of four different scFvs and antigens. J IMMUNOTHER , 28 (3) 203 - 211.

H

Hardcastle, IR and Ahmed, SU and Atkins, H and Calvert, AH and Curtin, NJ and Farnie, G and Golding, BT and Griffin, RJ and Guyenne, S and Hutton, C and Kallbad, P and Kemp, SJ and Kitching, MS and Newell, DR and Norbedo, S and Northen, JS and Reid, RJ and Saravanan, K and Willems, HMG and Lunec, J (2005) Isoindolinone-based inhibitors of the MDM2-p53 protein-protein interaction. BIOORG MED CHEM LETT , 15 (5) 1515 - 1520. 10.1016/j.bmcl.2004.12.061.

Hartley, JA and Hochhauser, D and Lee, M and Howard, PW and Thurston, DE (2005) DNA targeting with PBD and polyamide-based agents. In: CLINICAL CANCER RESEARCH. (pp. 9176S - 9176S). AMER ASSOC CANCER RESEARCH

Hartmann, G and Vassileva, V and Piquette-Miller, M (2005) Impact of endotoxin-induced changes in P-glycoprotein expression on disposition of doxorubicin in mice. DRUG METAB DISPOS , 33 (6) 820 - 828. 10.1124/dmd.104.002568.

Henderson, SR and Guiliano, D and Presneau, N and McLean, S and Frow, R and Vujovic, S and Anderson, J and Sebire, N and Whelan, J and Athanasou, N and Flanagan, AM and Boshoff, C (2005) A molecular map of mesenchymal tumors. GENOME BIOL , 6 (9) , Article R76. 10.1186/gb-2005-6-9-r76.
An open access publication. A version is also available from UCL Discovery.
 file

Ho, EA and Vassileva, V and Allen, C and Piquette-Miller, M (2005) In vitro and in vivo characterization of a novel biocompatible polymer-lipid implant system for the sustained delivery of paclitaxel. J CONTROL RELEASE , 104 (1) 181 - 191. 10.1016/j.jconrel.2005.02.008.

Hoskin, PJ (2005) Palliative radiotherapy for non-small-cell lung cancer: Which dose? ELSEVIER SCIENCE LONDON, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ (2005) Radioisotopes for metastatic bone pain. LANCET LTD, 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND

Hoskin, PJ (2005) Evaluation and mangement of the patient with bone metastases at presentation. In: Claude, JE and Rodolfo, CE and Lawrence, CE and Robert, CE and Gerard, S, (eds.) Textbook of Bone Metastases. (545 - 554). John Wiley & Sons

Hoskin, PJ (2005) Overview of treatment.Cancer Pain. In: Stephen, MMK, (ed.) Wall & Melzac's Textbook of Pain. Churchill Livingstone

Hoskin, PJ and Ahmedzai, S and Muers, MF (2005) Assessment and management of respiratory symptoms of malignant disease. In: Ahmedzai, S and Muers, MF, (eds.) Supportive care in respiratory disease. (463 - 486). Oxford University Press

Hoskin, PJ and Rojas, AM and Phillips, H and Saunders, MI (2005) Acute and late morbidity in the treatment of advanced bladder carcinoma with accelerated radiotherapy, carbogen, and nicotinamide. CANCER , 103 (11) 2287 - 2297. 10.1002/cncr.21048.

Hoskin, PJ and Smith, P and Maughan, TS and Gilson, D and Vernon, C and Syndikus, I and Linch, DC (2005) Long-term results of a randomised trial of involved field radiotherapy vs extended field radiotherapy in stage I and II Hodgkin lymphoma. CLINICAL ONCOLOGY , 17 (1) 47 - 53.

Howard, PW and Chen, ZZ and Gregson, SJ and Stephenson, M and Klee, S and Hartley, J and Suggit, M and Loadman, PM and Evans, D and Hartley, JA and Thurston, DE (2005) Design, synthesis and biological evaluation of ZC-423, a novel C2-aryl substituted pyrrolobenzodiazepine PBD) dimer. In: CLINICAL CANCER RESEARCH. (pp. 9015S - 9016S). AMER ASSOC CANCER RESEARCH

Howie, AJ and Pankhurst, T and Sarioglu, S and Turhan, N and Adu, D (2005) Evolution of nephrotic-associated focal segmental glomerulosclerosis and relation to the glomerular tip lesion. Kidney Int , 67 (3) 987 - 1001. 10.1111/j.1523-1755.2005.00162.x.

J

Jonathan, C-B (2005) Freezing used to kill cancer cells. The Sunday Times

K

Kelly, CMA and Lee, SM and Steele, JP (2005) Neoadjuvant chemotherapy for non-small cell lung cancer. In: Andrew, M, (ed.) Key Advances in Lung Cancer. (67 - 74). Aesculapius Medical Press: London, San Franscisco and Sydney.

Kogelberg, H and Tolner, B and Lowdell, M and Qureshi, U and Robson, M and Dearling, JL and Pedley, RB and Sharma, SK and Contreras, R and Taylor, ME and Begent, RHJ and Chester, KA (2005) Mechansims of clearance of the antibody-directed enzyme prodrug therapeutic, the mannosylated MFE-CP. In: (Proceedings) NCRI Cancer Conference Proceedings.

Kotecha, M and O'Hare, C and Wells, G and Howard, P and Thurston, D and Mantovani, R and Hartley, JA and Hochhauser, D (2005) Inhibition of DNA binding of the transcription factor complex NF-Y by a pyrrolobenzodiazepine-polyamide conjugate. In: CLINICAL CANCER RESEARCH. (pp. 9016S - 9016S). AMER ASSOC CANCER RESEARCH

Krause, M and Wohlfarth, J and Georgi, B and Pimentel, N and Dorner, D and Zips, D and Eicheler, W and Hessel, F and Short, SC and Joiner, MC and Baumann, M (2005) Low-dose hyperradiosensitivity of human glioblastoma cell lines in vitro does not translate into improved outcome of ultrafractionated radiotherapy in vivo. INTERNATIONAL JOURNAL OF RADIATION BIOLOGY , 81 (10) 751 - 758.

Kristeleit, R and Fong, P and Aherne, GW and de Bono, J (2005) Histone deacetylase inhibitors: emerging anticancer therapeutic agents? Clinical lung cancer. , 7 Suppl 1 S19 - 30.

L

Lee, M and Mahroof, S and Pringle, J and Short, SC and Briggs, TWR and Cannon, SR (2005) Diffuse pigmented villonodular synovitis of the foot and ankle treated with surgery and radiotherapy. INTERNATIONAL ORTHOPAEDICS , 29 (6) 403 - 405.

Lee, M and Sato, A and Kim, S and Scott, A and Ellington, M and Frazier, W and Handl, H and Price, C and Carnahan, V and Madsen, E and Summerville, K and McNulty, LA and Hudson, S and Hartley, J and Kiakos, K (2005) Novel class of duocarmycin analogs: Design, synthesis and biological evaluation of achiral seco-CBI analogs and CC-1065. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U344 - U344). AMER CHEMICAL SOC

LePla, RC and Landreau, CAS and Shipman, M and Hartley, JA and Jones, GDD (2005) Azinomycin inspired bisepoxides: influence of linker structure on in vitro cytotoxicity and DNA interstrand cross-linking. BIOORG MED CHEM LETT , 15 (11) 2861 - 2864. 10.1016/j.bcml.2005.03.091.

Lo, S and Tolner, B and Taanman, JW and Cooper, JM and Gu, M and Hartley, JA and Schapira, AHV and Hochhauser, D (2005) Assessment of the significance of mitochondrial DNA damage by chemotherapeutic agents. INT J ONCOL , 27 (2) 337 - 344.

M

Macbeth, F and Stephens, R and Hoskin, P (2005) Radiation dose in spinal cord compression. UNSPECIFIED

Makris, A (2005) Report on the 9th International conference on primary therapy of early breast cancer. (Breast Cancer Forum , pp. 2 - 6 ).

Makris, A (2005) Tamoxifen and exemestane:to switch or not to switch? UNSPECIFIED

Makris, A and Hisenbeck, SG and Yee, D and Osborne, KC and Elledge, RM and Harrison, M and Ostler, PJ and Mohsin, S and Gutierrez, CM and Chang, JC (2005) A prospective randomized multicenter gene expression study of docetaxel vs doxorubicin/cyclophosphamide preoperative trial in primary breast cancers. In: JOURNAL OF CLINICAL ONCOLOGY. (pp. 14S - 14S).

Marie-Egyptienne, DT and Cerone, MA and Londoño-Vallejo, JA and Autexier, C (2005) A human-Tetrahymena pseudoknot chimeric telomerase RNA reconstitutes a nonprocessive enzyme in vitro that is defective in telomere elongation. Nucleic Acids Res , 33 (17) 5446 - 5457. 10.1093/nar/gki848.

Martin, C and Ellis, T and McGurk, CJ and Jenkins, TC and Hartley, JA and Waring, MJ and Thurston, DE (2005) Sequence-selective interaction of the minor-groove interstrand cross-linking agent SJG-136 with naked and cellular DNA: Footprinting and enzyme inhibition studies. BIOCHEMISTRY-US , 44 (11) 4135 - 4147. 10.1021/bi0479813.

Mawdsley, S and Glynne-Jones, R and Grainger, J and Richman, P and Makris, A and Harrison, M and Ashford, R and Harrison, RA and Osborne, M and Livingstone, JI and Meyrick-Thomas, J and Northover, JMA and Windsor, A and Novell, R and Wallace, M (2005) Can histopathologic assessment of circumferential margin after preoperative pelvic chemoradiotherapy for T3-T4 rectal cancer predict for 3-year disease-free survival? International Journal of Radiation Oncology Biology Physics , 63 (3) 745 - 752.

McLean, SR and Gana-Weisz, M and Hartzoulakis, B and Frow, R and Whelan, J and Selwood, D and Boshoff, C (2005) Imatinib binding and cKIT inhibition is abrogated by the cKIT kinase domain I missense mutation Val(654)Ala. MOL CANCER THER , 4 (12) 2008 - 2015. 10.1158/1535-7163.MCT-05-0070.

McTiernan, A and Meyer, T and Michelagnoli, MP and Lewis, I and Whelan, JS (2005) A phase I/II study of doxorubicin, ifosfamide, etoposide and interval methotrexate in patients with poor prognosis osteosarcoma. Pediatric Blood and Cancer , 46 (3) 345 - 350.

N

Nooij, MA and Whelan, J and Bramwell, VHC and Taminiau, AT and Cannon, S and Hogendoorn, PCW and Pringle, J and Uscinska, BM and Weeden, S and Kirkpatrick, A and von Glabbeke, M and Craft, AW and European Osteosarcoma Intergrp, (2005) Doxorubicin and cisplatin chemotherapy in high-grade spindle cell sarcomas of the bone, other than osteosarcoma or malignant fibrous histiocytoma: a European Osteosarcoma Intergroup Study. EUR J CANCER , 41 (2) 225 - 230. 10.1016/j.ejca.2004.08.026.

O

O'Connell, NM and Saunders, RE and Lee, CA and Perry, DJ and Perkins, SJ (2005) Structural interpretation of 42 mutations causing factor XI deficiency using homology modeling. J THROMB HAEMOST , 3 (1) 127 - 138.

O'Donnell, P and Diss, TC and Whelan, J and Flanagan, AM (2005) Synovial sarcoma with radiological appearances of primitive neuroectodermal tumour/Ewing sarcoma: differentiation by molecular genetic studies. Skeletal Radiology , 35 (4) 233 - 239.

P

Padhani, AR and Ah-See, ML and Makris, A (2005) MRI in the detection and management of breast cancer. Expert review of anticancer therapy , 5 (2) 239 - 252.

Padhani, AR and Ah-See, ML and Taylor, NJ and Stirling, JJ and Daley, FM and Richamn, PI and d'Arcy, JA and Walker-Samual, S and Harris, AL and Collins, DJ and Leach, MO and Makris, A (2005) MRI correlates of tumour grade and hypoxia status in human breast cancer. In: Proceedings of the International Society of Magnetic Resonance Medicine.

Parker, LL and Anderson, FM and O'Hare, CC and Lacy, SM and Bingham, JP and Robins, DJ and Hartley, JA (2005) Synthesis of novel DNA cross-linking antitumour agents based on polyazamacrocycles. BIOORGAN MED CHEM , 13 (7) 2389 - 2395. 10.1016/j.bmc.2005.01.055.

Pedley, RB and El Emir, E and Sharma, SK and Qureshi, U and Dearling, JAB and R, HJ (2005) Therapeutic effects of the antivascular agent combretastatin A-1 phosphate on orthotopic and subcutaneous colorectal tumours in nude mice. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 943 - ?).

Peleg, M and Steele, R and Thomson, R and Patkar, V and Rose, T and Fox, J (2005) Open-source publishing of medical knowledge for creation of computer-interpretable guidelines. In: Miksch, S and Hunter, J and Keravnou, E, (eds.) ARTIFICIAL INTELLIGENCE IN MEDICINE, PROCEEDINGS. (pp. 156 - 160). SPRINGER-VERLAG BERLIN

Perkins, SJ and Gilbert, HE and Lee, YC and Sun, ZF and P, B (2005) Relating small angle scattering and analytical ultracentrifugation in multidomain proteins. In: Scott, DJ and Harding, SE and Rowe, AJ, (eds.) Modern Analytical Ultracentrifugation: Techniques and Method. (291 - 319). Royal Society of Chemistry: London,UK.

Plummer, ER and Middleton, MR and Jones, C and Olsen, A and Hickson, I and McHugh, P and Margison, GP and McGown, G and Thorncroft, M and Watson, AJ and Boddy, AV and Calvert, AH and Harris, AL and Newell, DR and Curtin, NJ (2005) Temozolomide pharmacodynamics in patients with metastatic melanoma: DNA damage and activity of repair enzymes 6-alkylguanine alkyltransferase and poly(ADP-ribose) polymerase-1. CLIN CANCER RES , 11 (9) 3402 - 3409.

Plummer, R and Middleton, M and Wilson, R and Evans, J and Jones, C and Olson, A and Boddy, A and Curtin, N and Kaufman, R and Harris, A and Johnston, P and Newell, H and Robson, L and Dewji, R and Calvert, H (2005) Final clinical, pharmacokinetic and pharmacodynamic results of the phase I study of the novel poly(ADP-ribose)polymerase (PARP) inhibitor, AG014699, in combination with temozolomide. In: CLINICAL CANCER RESEARCH. (pp. 9099S - 9099S). AMER ASSOC CANCER RESEARCH

Plummer, R and Middleton, M and Wilson, R and Jones, C and Evans, J and Robson, L and Steinfeldt, H and Kaufman, R and Reich, S and Calvert, AH (2005) First in human phase I trial of the PARP inhibitor AG-014699 with temozolomide (TMZ) in patients (pts) with advanced solid tumors. JOURNAL OF CLINICAL ONCOLOGY , 23 (16) 208S - 208S.

Plummer, R and Vidal, L and Perrett, R and Shaw, H and Pilkington, M and Hanwell, J and Temple, G and Fong, P and Amelsberg, A and Calvert, H and de Bono, J (2005) A phase 1 dose escalation study of BIBW 2992, an irreversible dual EGFR/HER2 receptor tyrosine kinase inhibitor, in a continuous schedule in patients with advanced solid tumors. In: CLINICAL CANCER RESEARCH. (pp. 8990S - 8990S). AMER ASSOC CANCER RESEARCH

Pors, K and Phillips, RM and Hartley, JA and Patterson, LH (2005) N-oxides of alkylating anthraquinones as hypoxia-targeting prodrugs. In: CLINICAL CANCER RESEARCH. (pp. 9053S - 9053S). AMER ASSOC CANCER RESEARCH

Price, CA and Lingerfelt, BM and Handl, HL and Kiakos, K and Hartley, JA and Lee, M (2005) Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole-imidazole polyamides. BIOORG MED CHEM LETT , 15 (12) 3151 - 3156. 10.1016/j.bmcl.2005.04.006.

Price, CA and Lingerfelt, BM and Handl, HL and Kiakos, K and Hartley, JA and Lee, M (2005) Sequence specific recognition of DNA by tailor-made hairpin conjugates of achiral seco-cyclopropaneindoline-2-benzofurancarboxamide and pyrrole-imidazole polyamides. Bioorg Med Chem Lett , 15 (12) 3151 - 3156. 10.1016/j.bmcl.2005.04.006.

Pritchard-Jones, K and Spendlove, I and Wilton, C and Whelan, J and Weeden, S and Lewis, I and Hale, J and Douglas, C and Pagonis, C and Campbell, B and Alvarez, P and Halbert, G and Durrant, LG (2005) Immune responses to the 105AD7 human anti-idiotypic vaccine after intensive chemotherapy, for osteosarcoma. BRITISH JOURNAL OF CANCER , 92 (8) 1358 - 1365.

R

Rades, D and Stalpers, LJA and Veninga, T and Hoskin, PJ (2005) Spinal reirradiation after short-course RT for metastatic spinal cord compression. International Journal of Radiation Oncology Biology Physics , 63 (3) 872 - 875.

Rades, D and Stalpers, LJA and Veninga, T and Schulte, R and Hoskin, PJ and Alberti, W (2005) Effectiveness and toxicity of reirradiation (Re-RT) for metastatic spinal cord compression (MSCC). STRAHLENTHERAPIE UND ONKOLOGIE , 181 (9) 595 - 600.

Rades, D and Stalpers, LJA and Veninga, T and Schulte, R and Hoskin, PJ and Obralic, N and Bajrovic, A and Rudat, V and Schwarz, R and Hulshof, MC and Poortmans, P and Schild, SE (2005) Evaluation of five radiation schedules and prognostic factors for metastatic spinal cord compression. Journal of Clinical Oncology , 23 (15) 3366 - 3376.

Ravn, P and Thornton, A and Chester, KA and Pedley, B and Davidson, B and Winslet, M and Ogunbiyi, O and Sharmaa, D and Meyer, T (2005) In situ selection of single chain antibodies by ex vivo perfusion of tumour-bearing human organs with phage display antibody libraries. In: (Proceedings) NCRI Cancer Conference Proceedings.

Robertson, JFR and Come, SE and Jones, SE and Beex, L and Kaufmann, M and Makris, A and Nortier, JWR and Possinger, K and Rutqvist, LE (2005) Endocrine treatment options for advanced breast cancer - the role of fulvestrant. EUROPEAN JOURNAL OF CANCER , 41 (3) 346 - 356.

Roos, DE and Turner, SL and O'Brien, PC and Smith, JG and Spry, NA and Burmeister, BH and Hoskin, PJ and Ball, DL (2005) Randomized trial of 8 Gy in 1 versus 20 Gy in 5 fractions of radiotherapy for neuropathic pain due to bone metastases (Trans-Tasman Radiation Oncology Group, TROG 96.05). Radiotherapy & Oncology , 75 (1) 54 - 63.

Rudd, RM and Gower, NH and Spiro, G and Lee, SM and Eisen, TG and Harper, PG and Hatton, M and Martin, WMC and Rankin, EM (2005) Is the tolerance to MIP Chemotherapy different Between English and Other European Populations? Journal of Clinical Oncology , 23 (25) 6270 - 6271.

Rudd, RM and Gower, NH and Spiro, SG and Eisen, TG and Harper, PG and Littler, JAH and Hatton, M and Johnson, PWM and Martin, WMC and Rankin, EM and James, LE and Gregory, WM and Qian, W and Lee, SM (2005) Gemcitabine plus Carboplatin versus Mitomycin,Ifosfamide, and Cisplatin in patients with stage IIIB orIV non-small-cell lung cancer: a phase III randomized study of the London Lung Cancer Group. Journal of Clinical Oncology , 23 (1) 142 - 153. 10.1200/JCO.2005.03.037.

S

Sainz-Pastor, N and Tolner, B and Huhalov, A and Kogelberg, H and Begent, RHJ and Chester, KA (2005) Expression and purification of recombinant carcinoembryonic antigen frm the yeast Pichia pastoris. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sainz-Pastor, N and Tolner, B and Huhalov, A and Kogelberg, H and Begent, RHJ and Chester, KA (2005) Expression and purification of recombinant carcinoembryonic antigen from the yeast Pichia pastoris. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sainz-Pastor, N and Tolner, B and Huhalov, A and Kogelberg, H and Lee, YC and Zhu, DL and Begent, RHJ and Chester, KA (2005) Deglycosylation to obtain stable and homogeneous Pichia pastoris-expressed N-A1 domains of carcinoembryonic antigen. International Journal of Biological Macromolecules , 39 (1 -3) 141 - 150.

Sato, A and McNulty, L and Cox, K and Kim, S and Scott, A and Daniell, K and Summerville, K and Price, C and Hudson, S and Kiakos, K and Hartley, JA and Asao, T and Lee, M (2005) A novel class of in vivo active anticancer agents: achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J Med Chem , 48 (11) 3903 - 3918. 10.1021/jm050179u.

Sato, A and McNulty, LA and Cox, K and Kim, S and Scott, A and Daniell, K and Summerville, K and Price, C and Hudson, S and Kiakos, K and Hartley, JA and Asao, T and Lee, M (2005) A novel class of in vivo active anticancer agents: Achiral seco-amino- and seco-hydroxycyclopropylbenz[e]indolone (seco-CBI) analogues of the duocarmycins and CC-1065. J MED CHEM , 48 (11) 3903 - 3918. 10.1021/jm050179u.

Seddon, BM and Cassoni, AM and Galloway, MJ and Rees, JH and Whelan, JS (2005) Fatal radiation myelopathy after high-dose busulfan and melphalan chemotherapy and radiotherapy for Ewing's sarcoma: A review of the literature and implications for practice. CLIN ONCOL-UK , 17 (5) 385 - 390. 10.1016/j.clon.2005.03.004.

Seddon, BM and McTiernan, AM and Michelagnoli, MP and Gabbie, S and Daw, S and Whelan, JS (2005) High-dose ifosfamide in relapsed or progressive Ewing's sarcoma. In: Sarcoma Meeting Stuttgart, June, 2005. Sarcoma 2005; 9(1/2): 108 (P150).

Sharma, SK and Bagshawe, KD and Begent, RH (2005) Advances in antibody-directed enzyme prodrug therapy. Curr Opin Investig Drugs , 6 (6) 611 - 615.

Sharma, SK and Griffin, N and Mayer, A and Tolner, B and Shahbakhti, H and Chester, KA and Begent, RHJ (2005) Immunogenicity of a glycosylates antibody-enzyme fusion protien (MFECP1) in a phase I/II clinical study of ADEPT. In: (Proceedings) NCRI Cancer Conference Proceedings.

Sharma, SK and Pedley, RB and Bhatia, J and Boxer, GM and El-Emir, E and Qureshi, U and Tolner, B and Lowe, H and Michael, NP and Minton, N and Begent, RHJ and Chester, KA (2005) Sustained tumor regression of human colorectal cancer xenografts using a multifunctional mannosylated fusion protein in antibody-directed enzyme prodrug therapy. CLIN CANCER RES , 11 (2) 814 - 825.

Sharma, SK and Pedley, RB and Meyer, A and Tolner, B and Griffin, N and Green, A and Boxer, GM and Begent, RHJ and and Chester, KA (2005) Pharmacokinetics and pharmakodynamics of a glycosylated antibody-enzyme fusion protein for ADEPT. In: (Proceedings) Proceedings American Association for Cancer Research. (pp. 984 - ?).

Short, S and Bourne, S and Martindale, C and Woodcock, M and Jackson, SP (2005) DNA damage responses at low radiation doses. Radiation Research , 164 (3) 292 - 302. 10.1667/RR3421.1.

Short, S and Buffa, F and Koritzinsky, M and Wouters, B and Bentzen, SM (2005) Radiation induced changes in gene expression in human glioma cells. In: Proc 6th Wolfsberg Conference on Molecular Radiation Biology/Oncology.

Short, S and C, B and F, K and M, W and B, B and S, M (2005) UNSPECIFIED In: (Proceedings) 6th Wolfsberg Conference on Molecular Radiation Biology/Oncology.

Short, S and Hoskin, P and Wong, W (2005) Ovulation and increased FDG uptake on PET: Potential for a false-positive result. LIPPINCOTT WILLIAMS & WILKINS, 530 WALNUT ST, PHILADELPHIA, PA 19106-3261 USA

T

Taherbhai, Z and Bailey, S and Sutterfield, A and Buchmueller, K and Nguyen, B and Kotecha, M and Hochhauser, D and Hartley, J and Wilson, D and Lee, M (2005) ZT-65B, a hairpin polyamide that binds to the inverted CCAAT box (ICB) site of the human multidrug resistant (MDR1) gene: Design, DNA binding, and biological studies. In: ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY. (pp. U542 - U543). AMER CHEMICAL SOC

Taylor, NJ and Ah-See, ML and Stirling, JJ and d'Arcy, JA and Collins, DJ and Walker-Samuel, S and Leach, MO and Makris, A and Padhani, AR (2005) Pre-and post-chemotherapy comparisons of calculated rBV and rBF with signal intensity drop on T2* dynamic contrast-enhanced MRI of breast cancers. In: Proceedings of the the International Society of Magnetic Resonance Medicine. (pp. 91 - 91).

Thomson, A and Mayne, N and Bamford, A and Daw, S and Whelan, J and Michelagnoli, M (2005) Acute anthracycline-induced cardiotoxicity in children and adolescents treated for bone cancer. In: SIOP XXXVI Meeting, Vancouver, Canada, Nov 2005.

Tolner, B and Taylorson, CJ and Kogelberg, H and Huhalov, S and Robson, L and Begent, RHJ and Chester, KA (2005) A humanized ADEPT system using mutated human pancreatic ribonuclease. In: (Proceedings) NCRI Cancer Conference Proceedings.

Toth, JL and Trzupek, JD and Flores, LV and Kiakos, K and Hartley, JA and Pennington, WT and Lee, M (2005) A novel achiral seco-amino-cyclopropylindoline (CI) analog of CC-1065 and the duocarmycins: design, synthesis and biological studies. Med Chem , 1 (1) 13 - 19.

V

Valle, JW and Dangoor, A and Beech, J and Lee, SM and Scarffe, JH and Swindell, R and Ranson, M (2005) Treatment of inoperable hepatocellular carcinoma (HCC) with pegylated liposomal doxorubicin (PLD) – results of a phase II study. British Journal of Cancer , 92 (4) 628 - 630.

Venables, K and Miles, EA and Hoskin, PJ and Aird, EGA (2005) Verification films: A study of the daily and weekly reproducibility of breast patient set-up in the START trial. Clinical Oncology , 17 (5) 337 - 342.

Vidal, L and Leslie, M and Sludden, J and Griffin, MG and Plummer, R and Judson, I and Lee, C and Greystoke, A and Calvert, AH and Boddy, AV (2005) A phase I and pharmacodynamic study of a 7 day infusion schedule of the DNMT1 antisense compound MG98. JOURNAL OF CLINICAL ONCOLOGY , 23 (16) 209S - 209S.

Vigor, K and Lee, YC and Farrell, D and Huhalov, S and Robson, L and Begent, RHJ and Chester, KA (2005) Antibody-nanoparticle complexation for hyperthermic treatment of tumours. In: (Proceedings) NCRI Cancer Conference Proceedings.

Violet, JA and Dearling, JLJ and Marley, SJ and Green, AJ and Begent, RHJ and and, PRB (2005) Dose fractionation reduces efficacy of radioimmunotherapy without decreasing toxicity. In: European Journal of Nuclear Medicine and Molecular Imaging. (pp. 207 - ?).

W

Westbury, C and Yarnold, J (2005) Can a 'low risk' subgroup be identified in whom radiotherapy can safely be omitted after breast conservation surgery? In: MD, RL, (ed.) The effective management of breast cancer. (? - ?).

Whelan, JS (2005) Osteosarcoma. In: Eden, OB and Barr, R and Bleyer, A and Whiteson, M, (eds.) Cancer and the Adolescent. Blackwell Publishing: Oxford.

Whelan, JS and McTiernan, AM and Weston, C and Ahrens, S and Grimer, R and Lewis, I and Douglas, C and Cassoni, A and Spooner, D and Paulussen, M and Jurgens, H and Craft, A (2005) Differences in survival between Study Groups detected in an international randomised study: analysis of Eicess 92. In: Sarcoma Meeting Stuttgart, June, 2005. Sarcoma 2005; 9(1/2): 115 (P177).

This list was generated on Wed May 22 06:50:46 2013 BST.